A R T I C L E S
Okamoto et al.
in anhydrous DMF (10 mL) was stirred at room temperature. After 15
min, propargylamine (0.139 mL, 2.03 mmol) was added, and the
mixture was stirred at room temperature for 2.5 h. The resulting mixture
was concentrated in vacuo and diluted with ethyl acetate. This solution
was washed with sat. NH4Cl solution and brine, dried over MgSO4,
filtered and evaporated. The crude product was purified by silica gel
column chromatography (chloroform-methanol ) 30:1) to yield 5a
(500 mg, 87%) as a yellow solid: 1H NMR (CDCl3, 400 MHz) δ )
8.62 (d, 1H, J ) 9.3 Hz), 8.25 (d, 1H, J ) 7.6 Hz), 8.26-8.04 (7H),
6.30 (br, 1H), 4.45 (dd, 2H, J ) 5.2, 2.6 Hz), 2.35 (t, 1H, J ) 2.6 Hz);
13C NMR (DMSO-d6, 125 MHz) δ ) 169.5, 132.8, 131.1, 130.6, 128.9,
128.84, 128.81, 127.0, 126.4, 125.9, 125.8, 124.7, 124.5, 124.30, 124.26,
124.2, 79.4, 72.1, 30.0; FABMS (NBA/CDCl3), m/z 283 (M+), HRMS
calcd. for C20H13NO (M+) 283.0997, found 283.0996.
mixture was stirred for 5 min at room temperature. The resulting mixture
was evaporated and purified by recycling preparative HPLC (JAIST
LC-908, JAIGEL GS-310, methanol) to yield 4a (12 mg, 27%): 1H
NMR (DMSO-d6, 500 MHz) δ ) 11.63 (br, 1H), 9.22 (t, 1H, J ) 5.6
Hz), 8.53 (d, 1H, J ) 9.6 Hz), 8.55-8.10 (7H), 8.14 (s, 1H), 8.12 (dd,
1H, J ) 9.6, 8.0 Hz), 6.13 (t, 1H, J ) 6.6 Hz), 5.23 (br, 1H), 5.10 (br,
1H), 4.44 (d, 2H, J ) 5.5 Hz), 4.26-4.21 (m, 1H), 3.64-3.56 (m,
2H), 2.19-2.12 (m, 2H); 13C NMR (DMSO-d6, 125 MHz) δ ) 168.5,
161.8, 149.5, 143.6, 131.7, 131.0, 130.7, 130.1, 128.3, 128.2, 127.9,
127.1, 126.5, 125.8, 125.6, 125.2, 124.6, 124.3, 123.7, 123.6, 98.2,
89.6, 87.6, 84.7, 74.5, 70.2, 61.0, 40.0, 29.4; FABMS (NBA/DMSO),
m/z 510 ([M+H]+), HRMS calcd. for C29H24N3O6 ([M+H]+) 510.1665,
found 510.1667.
5-[3-(1-Pyrenylmethylamino)propynyl]-5′-O-(4,4′-dimethoxy-
trityl)-2′-deoxyuridine (2b). To a solution of 1 (523 mg, 0.961 mmol),
5b (333 mg, 1.24 mmol), and triethylamine (0.530 mL, 3.78 mmol) in
10 mL of anhydrous DMF was added tetrakis(triphenylphosphine)-
palladium(0) (492 mg, 0.426 mmol) and copper(I) iodide (162 mg,
0.852 mmol) under nitrogen. The mixture was stirred at room
temperature for 12 h. The resulting mixture was concentrated in vacuo
and diluted in ethyl acetate. This solution was washed with 5% (w/V)
EDTA solution and 5% (w/V) sodium bisulfite solution, dried over Na2-
SO4, filtered and evaporated. The crude product was purified by silica
gel column chromatography (chloroform-methanol ) 50:1) yield 2b
(465 mg, 60%) as a white solid: 1H NMR (DMSO-d6, 400 MHz) δ )
11.70 (s, 1H), 8.45-7.96 (11H), 7.35-7.09 (9H), 6.89-6.75 (4H), 6.13
(t, 1H, J ) 6.7 Hz), 5.35 (d, 1H, J ) 4.4 Hz), 4.38 (d, 2H, J ) 5.7
Hz), 4.31-4.28 (m, 1H), 3.94-3.89 (m, 1H), 3.63 (s, 3H), 3.60 (s,
3H), 3.40 (d, 2H, J ) 3.1 Hz), 3.23 (dd, 1H, J ) 10.2, 5.0 Hz), 3.07
(dd, 1H, J ) 10.2, 2.4 Hz), 2.28 (dt, 1H, J ) 13.4, 6.8 Hz), 2.20 (ddd,
1H, J ) 13.4, 6.4, 3.6 Hz); 13C NMR (DMSO-d6, 125 MHz) δ ) 161.7,
158.0, 157.9, 149.3, 144.6, 142.5, 135.5, 130.7, 130.3, 130.0, 129.7,
129.6, 129.5, 128.7, 128.6, 127.8, 127.5, 127.4, 127.3, 127.0, 126.8,
126.5, 126.0, 125.0, 124.9, 124.5, 124.1, 123.92, 123.85, 113.2, 113.13,
113.09, 98.8, 86.0, 85.81, 85.80, 85.79, 84.9, 79.1, 75.3, 70.4, 63.6,
54.93, 54.87, 54.86, 49.2, 39.9, 38.0, 37.8; FABMS (NBA/DMSO),
m/z 798 ([M+H]+), HRMS calcd. for C50H43N3O7 ([M+H]+) 798.3179,
found 325.1473.
N-(1-Pyrenylmethyl)propargylamine (5b). To a solution of pyren-
ecarboxaldehyde (1.00 g, 4.34 mmol) and propargylamine (0.365 mL,
5.21 mmol) in methanol (10 mL) was added sodium cyanoborohydride
(327 mg, 5.21 mmol). The mixture was stirred at room temperature
for 1 h. The resulting mixture was concentrated and diluted in ethyl
acetate. This solution was washed with sat. NH4Cl and sat. NaHCO3,
dried over Na2SO4, filtered and evaporated. The crude product was
purified by silica gel column chromatography (chloroform-methanol
) 50:1) to yield 5b (901 mg, 77%) as a white solid: 1H NMR (CDCl3,
400 MHz) δ ) 8.42-7.97 (9H), 4.58 (s, 2H), 3.56 (s, 2H), 2.39 (t,
1H, J ) 2.2 Hz); 13C NMR (DMSO-d6, 125 MHz) δ ) 133.8, 130.7,
130.3, 129.9, 128.7, 127.3, 127.2, 127.0, 126.7, 126.0, 124.94, 124.90,
124.5, 124.1, 123.9, 123.7, 82.9, 73.9, 49.2, 37.1; FABMS (NBA/
CDCl3), m/z 269 (M+), HRMS calcd. for C20H15N (M+) 269.1204, found
269.1204.
5-[3-(1-Pyrenecarboxamido)propynyl]-5′-O-(4,4′-dimethoxytrityl)-
2′-deoxyuridine (2a). To a solution of 5-iodo-5′-O-(4,4′-dimethox-
ytrityl)-2′-deoxyuridine5 (1, 523 mg, 0.961 mmol), 5a (323 mg, 1.24
mmol), and triethylamine (0.53 mL, 3.79 mmol) in 10 mL of anhydrous
DMF was added tetrakis(triphenylphosphine)palladium(0) (492 mg,
0.426 mmol) and copper(I) iodide (162 mg, 0.852 mmol) under
nitrogen. The mixture was stirred at room temperature for 12 h. The
resulting mixture was concentrated in vacuo and diluted with ethyl
acetate. This solution was washed with 5% (w/V) EDTA solution and
5% (w/V) sodium bisulfite solution, dried over Na2SO4, filtered and
evaporated. The crude product was purified by silica gel column
chromatography (chloroform-methanol ) 50:1) to yield 2a (465 mg,
60%) as a yellow solid: 1H NMR (DMSO-d6, 400 MHz) δ ) 11.70
(br, 1H), 9.13 (t, 1H, J ) 5.5 Hz), 8.51 (d, 1H, J ) 5.6 Hz), 8.37-
8.08 (8H), 7.96 (s, 1H), 7.42-7.20 (9H), 6.88 (dd, 4H, J ) 9.2, 3.2
Hz), 6.11 (t, 1H, J ) 6.8 Hz), 5.33 (d, 1H, J ) 4.4 Hz), 4.29 (d, 2H,
J ) 4.8 Hz), 3.93-3.90 (m, 1H), 3.73 (s, 1H), 3.69 (s, 3H), 3.68 (s,
3H), 3.28-3.24 (m, 1H), 3.07 (dd, 1H, J ) 10.3, 2.7 Hz), 2.29 (dt,
1H, J ) 13.2, 6.4 Hz), 2.19 (ddd, 1H, J ) 13.6, 6.4, 3.5 Hz); 13C
NMR (DMSO-d6, 125 MHz) δ ) 168.4, 161.6, 158.1, 158.0, 149.3,
144.8, 143.2, 135.6, 135.2, 131.7, 131.0, 130.7, 130.1, 129.71, 129.65,
129.59, 128.3, 128.1, 127.90, 127.85, 127.5, 127.1, 126.6, 126.5, 125.8,
125.6, 125.2, 124.6, 124.3, 123.74, 123.56, 113.23, 113.19, 98.3, 89.6,
85.9, 85.8, 85.0, 79.1, 74.1, 70.5, 63.7, 55.0, 54.9, 29.4; FABMS (NBA/
DMSO), m/z 811 (M+), HRMS calcd. for C50H41N3O8 (M+) 811.2894,
found 811.2883.
5-[3-(1-Pyrenylmethylamino)propynyl]-5′-O-(4,4′-dimethoxy-
trityl)-2′-deoxyuridine 3′-O-(2-cyanoethyl)-N,N-diisopropylphos-
phoramidite (3b). To a solution of 2b (48 mg, 60 µmol) and tetrazole
(4.9 mg, 71 µmol) in anhydrous acetonitrile (0.6 mL) was added
2-cyanoethyl tetraisopropylphosphorodiamidite (22 µL, 70 µmol) under
nitrogen. The mixture was stirred at room temperature for 1 h. The
mixture was filtered and used for oligodeoxynucleotide synthesis
without further purification.
5-[3-(1-Pyrenylmethylamino)propynyl]-2′-deoxyuridine (4b). To
a solution of 2b (75 mg, 94.1 µmol) in 1 mL of dichloromethane was
added 3% trichloroacetic acid in dichloromethane (3 mL) and the
mixture was stirred for 5 min at room temperature. The resulting mixture
was evaporated and purified by silica gel column chromatography
(chloroform-methanol ) 50:1) yield 4b (35 mg, 75%): 1H NMR (CD3-
OD, 400 MHz) δ ) 8.51-8.48 (2H), 8.33-8.30 (4H), 8.22-8.08 (4H),
6.23 (t, 1H, J ) 6.4 Hz), 5.12 (s, 2H), 4.39 (dt, 1H, J ) 6.4, 3.6 Hz),
4.27 (s, 2H), 3.96 (q, 1H, J ) 3.6 Hz), 3.80 (dd, 1H, J ) 12.0 Hz),
3.72 (dd, 1H, J ) 12.0, 3.2 Hz), 2.36 (ddd, 1H, J ) 13.6, 6.4, 3.6 Hz),
2.22 (dt, 1H, J ) 13.6, 6.4 Hz); 13C NMR (CD3OD, 125 MHz) δ )
164.5, 151.0, 146.6, 134.0, 132.6, 132.0, 131.2, 130.3, 130.0, 129.8,
127.7, 127.2, 127.0, 126.2, 126.1, 125.6, 123.2, 98.4, 89.4, 87.5, 72.0,
62.5, 58.3, 49.9, 49.5, 49.3, 42.0, 38.3; FABMS (DTT-TG/CH3OH),
m/z 496 ([M+H]+), HRMS calcd. for C29H25N3O5 ([M+H]+) 496.1868,
found 496.1872.
5-[3-(1-Pyrenecarboxamido)propynyl]-5′-O-(4,4′-dimethoxytrityl)-
2′-deoxyuridine
3′-O-(2-cyanoethyl)-N,N-diisopropylphosphor-
amidite (3a). To a solution of 2a (57 mg, 70 µmol) and tetrazole (5.4
mg, 77 µmol) in anhydrous acetonitrile (0.8 mL) was added 2-cyano-
ethyl tetraisopropylphosphorodiamidite (25 µL, 77 µmol) under nitro-
gen. The mixture was stirred at room temperature for 1h. The mixture
was filtered and used for oligodeoxynucleotide synthesis without further
purification.
4-N-(N,N-Dimethylaminomethylidenyl)-5-iodo-5′-O-(4,4′-dimeth-
oxytrityl)-2′-deoxycytidine (7). To a solution of the 5-iodo-2′-
deoxycytidine (6, 500 mg, 1.42 mmol) in dry DMF (5 mL) was added
N,N-dimethylformamide dimethylacetal (5.3 mL, 30.0 mmol), and the
5-[3-(1-Pyrenecarboxamido)propynyl]-2′-deoxyuridine (4a). To
a solution of 2a (70 mg, 86.2 µmol) in 1 mL of dichloromethane was
added 3% trichloroacetic acid in dichloromethane (2 mL) and the
9
4826 J. AM. CHEM. SOC. VOL. 126, NO. 15, 2004